首页> 外国专利> NKG2C as prognostic marker in multiple sclerosis

NKG2C as prognostic marker in multiple sclerosis

机译：NKG2C作为多发性硬化症的预后指标

页面导航

摘要
著录项
相似文献

摘要

The present invention provides an in vitro method for determining the clinical prognosis of a subject diagnosed of multiple sclerosis (MS), the method comprising the step of determining the genotype of NKG2C gene in an isolated test sample from the subject.;In addition the present invention provides the use of means for determining the genotype of NKG2C.;The method of the invention provides valuable information about the clinical progression of MS.

机译：本发明提供了一种用于确定诊断为多发性硬化症（MS）的受试者的临床预后的体外方法，该方法包括确定 NKG2C 基因的基因型的步骤。另外，本发明提供了用于确定 NKG2C基因型的手段的用途。”本发明的方法提供了有关MS临床进展的有价值的信息。 展开▼

著录项

公开/公告号EP2952899A1

专利类型

公开/公告日2015-12-09

原文格式PDF

申请/专利权人 FUNDACIÓ INSTITUT MAR DINVESTIGACIONS MÈDIQUES (IMIM);
展开▼

申请/专利号EP20140171499

发明设计人 ROQUER GONZALEZ JAUME;MUNTASELL CASTELLVI AURA;MUNTEIS OLIVAS ELVIRA;MARTÍNEZ RODRIGUÉZ JOSÉ ENRIQUE;LÓPEZ-BOTET MIGUEL;
展开▼

申请日2014-06-06

分类号G01N33/68;

国家 EP

入库时间 2022-08-21 14:47:50

相似文献

专利

外文文献

中文文献

1. 多发性骨髓瘤预后不良生物标志物及筛选方法、预后分层模型和应用 [P] . 中国专利： CN114134227A . 2022-03-04

2. 用于治疗与多发性硬化症相关联的抑郁性症状的电子设备和方法 [P] . 中国专利： CN113892147A . 2022-01-04

3. DIAGNOSTIC AND PROGNOSTIC MARKERS AND TREATMENT STRATEGIES FOR MULTIPLE SCLEROSIS [P] . 世界知识产权组织专利： WO2007109733A3 . 2008-01-24

机译：多发性硬化的诊断和预后标志及治疗策略

4. DIAGNOSTIC AND PROGNOSTIC MARKERS AND TREATMENT STRATEGIES FOR MULTIPLE SCLEROSIS [P] . 世界知识产权组织专利： WO2007109733A2 . 2007-09-27

机译：多发性硬化的诊断和预后标志及治疗策略

5. "METHOD FOR DELAYING CLINICALLY DEFENTIVE MULTIPLE SCIENCE ACCESS IN A PATIENT RISK OF CLINICALLY DEVELOPING MULTIPLE DECLINING PROCEDURE IN THE CURRENT DEVELOPMENT OF THE PROGRESS OF MONITOR RISK DEVELOPING CLINICALLY DEFINING MULTIPLE SCLEROSIS, A METHOD TO REDUCE DEFINITIVE MULTIPLE SCLEROSIS SYMPTOMS IN A PATIENT SUGGESTIVE MULTIPLE SCLEROSIS, METHOD TO DELAY THE PROGRESS FOR CLINICALLY DEFINING MULTIPLE SCLEROSIS IN A PATIENT WHO HAS A FIRST CLINICAL EVENT SUGGESTED BY THE MUSCLES [P] . BRPI0819001A2 . 2014-10-07

机译： “在临床风险不断发展的多个阶段中，临床上不断定义多重误差的方法，旨在在临床上持续定义多个误差，从而在临床上持续不断地改进多个指标，从而在临床上不断定义多重误差的过程中，对临床上不断发展的多重风险的临床风险进行评估。延迟有肌肉建议的第一个临床事件的患者中临床上确定多发性硬化症的进展的方法

1. Copy Number Aberrations of Multiple Genes Identified as Prognostic Markers for Extrahepatic Metastasis-free Survival of Patients with Hepatocellular Carcinoma [J] . Zhong-zheng ZHU, Ling-ling BAO, Kun ZHAO, 当代医学科学(英文) . 2019,第005期

2. Prognostic value of preoperativer prognostic nutritional index and its associations with systemic inflammatory response markers in patients with stage Ⅲ colon cancer [J] . Jianhong Peng, Rongxin Zhang, Yixin Zhao, 癌症（英文版） . 2017,第011期

3. Intrathecal IgM as a Prognostic Marker in Multiple Sclerosis [J] . Molecular diagnosis & therapy . 2020,第3期

4. The Follow Up of Patients with Multiple Sclerosis Before and After Treating with Disease Modifying Therapies, Modified Rio Score as A Prognostic Marker [J] . Soysal A., Ozerden M., Uygunoglu U., Multiple sclerosis: clinical and laboratory research . 2015,第6期

5. Multiple sclerosis risk genotypes correlate with an elevated cerebrospinal fluid level of the suggested prognostic marker CXCL13 [J] . LindénM., KhademiM., LimaBomfimI., Multiple sclerosis: clinical and laboratory research . 2013,第7期

6. Prognostic Value of Brain Tissue Pathological Changes in Patients with Clinically Isolated Syndromes (CIS) Suggestive of Multiple Sclerosis Using Magnetization Transfer Ratio (MTR) [C] . Fooladi, M., Alam, Engineering in Medicine and Biology Society, 2007 Annual International Conference of the IEEE . 2007

7. The quest for a myelin specific magnetic resonance marker of multiple sclerosis pathology: Myelin water imaging. [D] . Laule, Cornelia. 2005

8. Olfactory dysfunction as a prognostic marker for disability progression in Multiple Sclerosis: An olfactory event related potential study [O] . Rosella Ciurleo, Lilla Bonanno, Simona De Salvo, -1

9. Clinically isolated syndrome: prognostic markers for conversion to multiple sclerosis and initiation of disease-modifying therapy [O] . Tatsuo Kohriyama 2011

1. Vitamin D Level in Multiple Sclerosis Patients. Could Vitamin D Level Be Routine Investigation for Multiple Sclerosis Patients? [J] . Mohamed Hamdy Ibrahim ,Taha Kamel Alloush ,Mohamed Khalid Abdul Rahim . 神经系统科学与医药（英文） . 2014,第5期

2. Onodera's Prognostic Nutritional Index is a novel and useful prognostic marker for gastrointestinal stromal tumors [J] . Hao Wang ,Ying-Ying Xu ,Jun You . 世界胃肠外科杂志:英文版(电子版) . 2021,第10期

3. Vascular markers CD31,CD34,actin,VEGFB,and VEGFR2,are prognostic markers for malignant development in benign endometrial polyps [J] . Bodil Hvingel ,Marit Lieng ,Borghild Roald . 妇产科期刊（英文） . 2012,第1期

4. 习练五禽戏干预多发性硬化症1例的验案分析 [C] . 张衍泽 ,霍文娟 ,高巧荣 . 世界医学气功学会第九届学术交流会议 . 2016

5. 血液流变学指标及D-二聚体在多发性骨髓瘤患者诊断及预后中意义的临床研究 [A] . 刘丹兰 . 2020